Συγγραφή βιβλίων – Δημοσιεύσεις

1) [31β] Effect of aldose reductase inhibition on cardiovascular reflex tests in patients with definite Diabetic autonomic neuropathy
over a period of two years.
T.DIDANGELOS, D. Karamitsos, V. Athyros, G. Kourtoglou
Journal of Diabetes and its Complications, 12; 4: 201 -207, 1998.

2) [18β] Effect of chronic quinapril administration on heart rate variability in patients with Diabetic autonomic neuropathy.
A. Kontopoulos, V. Athyros, T.DIDANGELOS, A. Papageorgiou, M. Avramidis, M. Mavroudi, D. Karamitsos.
Diabetes Care, 20: 355 – 361, 1997.

3) [26β] Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate Diabetic autonomic neuropathy.
T.DIDANGELOS, V. Athyros, D.Karamitsos, A. Papageorgiou, G.Kourtoglou,
A. Kontopoulos.
Clinical Drug Investigation, 15 (2): 111 -121, 1998.

4) [33β] Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
V. Athyros, A. Papageorgiou, H. Hatzikonstandinou, T. DIDANGELOS, Carina, D. Kranitsas, A. Kontopoulos.
American Journal of Cardiology, 80: 608 – 613, 1997.

5) [34γ] Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy.
V. Athyros, T.DIDANGELOS, D. Karamitsos, A. Papageorgiou,
H. Boudoulas, A. Kontopoulos.
Acta Cardiologica 53 (4) : 201 – 209, 1998.

6) [32β] The natural history of recently diagnosed autonomic neuropathy over a period of 2 years.

D.T.Karamitsos, T.P.DIDANGELOS, V.G. Athyros, A. G. Kontopoulos.
Diabetes Research and Clinical Practice, 42; 55 – 63, 1998.

7) [17] Facts and reservations about the ADA’s diet recommendations for diabetic individuals.
Karamitsos, G. Kourtoglou, T. DIDANGELOS.
Scientific Annals of the Medical Faculty 25 (2): 57 – 59, 1998.

8) [59β]. Depression, quality of life and diabetes mellitus.
Pita R., Fotakopoulou O., Kiosseoglou G., Zafiri M., Roikou K., Simos G.,
Didaggelos T., Karamitsos T..
HIPPOKRATIA (2002), 6 Suppl. 1, 44 – 47.

9) [63α] Left ventricular systolic and diastolic function in normotensive type-1 diabetic patients with or without autonomic neuropathy. A radionuclide ventriculography study.
T.P.DIDANGELOS, G.A.Arsos, D.T.Karamitsos,V.G.Athyros, N.D.Karatzas.
Diabetes Care 26 (7): 1955 – 1960, 2003.

10) [66β] Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus.
Athyros VG, Papageorgiou AA, Symeonidis AN, DIDANGELOS TP, Pehlivanidis AN, Bouloukos VI, Mikhailidis DP; GREACE Study Collaborative Group.
Angiology Nov-Dec; 54(6):679-90, 2003.

11) [74β] The ORLIstat and Cardiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) study.
T.P.DIDANGELOS, A.K.Thanopoulou, S.H.Bousboulas, C.L.Sambanis, V.G.Athyros, E.A.Spanou, K.C.Dimitriou, S.I.Pappas, B.G.Karamanos, and D.T.Karamitsos.
Current Medical Research and Opinion 20 (7): 1393-1401, 2004.

12) [79] Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS GREECE Multicentre Study
Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Ganotakis ES; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Elisaf M
Current Medical Research and Opinion 20 (11): 1691-1701, 2004

13) [94] Targeting vascular risk in patients with metabolic syndrome but without diabetes.
V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou, T.P. Didangelos, Α.Peletidou,
T. Kleta, A. Karagiannis, A.I. Kakafika, K. Tziomalos and M. Elisaf.
METABOLISM 54: 1065 – 1074, 2005

14) Heart failure after thiazolidinedione therapy.
Sambanis Ch, Tziomalos K, Kehagia E, Nakou E, Randou E, Kountana E,
Didangelos T, Karamitsos D.
Hippokratia, 9,2: 87-91, 2005.

15) [63β]Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy.
T.Didangelos, G.Arsos, D.Karamitsos, V. Athyros, S.Georga, N.Karatzas
Journal of Diabetes and Its Complications 20: 1– 7, 2006.

16) [97] V.G. Athyros, D.P. Mikhailidis, T. P. Didangelos, O.I. Giouleme, E.N. Liberopoulos, A. Karagiannis, A.I. Kakafika, K. Tziomalos, A.K. Burroughs and M.S. Elisaf.
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomized study.
Current Medical Research and Opinion 22 (5): 873 – 883, 2006.

17) [98α] Usefulness of colour tissue Doppler imaging in assessing aortic elastic properties in Type 1 diabetic patients
T. D. Karamitsos, H. I. Karvounis, T. P. Didangellos, C. E.Papadopoulos, E. G. Dalamanga,D. T. Karamitsos, G. E. Parharidis and G. E. Louridas
Diabetic Medicine 23, 1201–1206, 2006.

18) [99] Early diastolic impairment of diabetic heart: The significance of right ventricle
T. D. Karamitsos , H. I. Karvounis , E. G. Dalamanga, C. E.Papadopoulos, T. P. Didangellos , D. T. Karamitsos, G. E. Parharidis, G. E. Louridas
International Journal of Cardiology, 114:218 – 223, 2007

19) [100] Aortic Elastic Properties Are Related to Left Ventricular Diastolic Function in Patients with Type 1 Diabetes Mellitus.
Karamitsos TD, Karvounis HI, Didangelos TP, Papadopoulos CE, Kachrimanidou MK, Selvanayagam JB, Parharidis GE.
Cardiology. 2007 Aug 14;109(2):99-104

20) [117] Impact of Autonomic Neuropathy on Left Ventricular Function in Normotensive Type1 Diabetic Patients A tissue Doppler echocardiographic study.
T. D. Karamitsos, H.Karvounis, T. Didangelos, G.Parcharidis, D. T. Karamitsos.
Diabetes Care 31:325–327, 2008

21) [118] Impact of Autonomic Neuropathy on Left Ventricular Function in Normotensive Type 1 Diabetic Patients: a Tissue Doppler Echocardiographic Study
T.D. Karamitsos, H.Karvounis, T. Didangelos, G.Parcharidis, and D. T. Karamitsos.
Diabetes Care 2008 31: e41

22) [119] Diabetes mellitus and cerebrovascular disease: which are the actual data?
A.I. Hatzitolios, T.P. Didangelos, A. T. Zantidis, K.Tziomalos, G. A. Giannakoulas,
D. T. Karamitsos.
Journal of Diabetes and Its Complications 23 (2009) 283–296

23) [120] Stochastic Resonance—A Method to Reverse Sensory Loss?

JOHN DOUPIS, TRIANTAFYLLOS DIDANGELOS, ARISTIDIS VEVES
Τhe Pain Practitioner, 2009, 19 (2), 55-60

24) [128α] Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.
Athyros VG, Hatzitolios A, Karagiannis A, Didangelos TP, Iliadis F, Dolgyras S, Vosnakidis T, Vasiliadis P, Malias I, Tziomalos K, Samouilidou M, Mikhailidis DP; INDEED Collaborative Group
Curr Med Res Opin. 2009 Aug;25(8):1931-40

25) [156] Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review.
Moralidis E, Didangelos T, Arsos G, Athyros V, Mikhailidis DP.
Diabetes Metab Res Rev. 2010 Jul;26(5):336-47

26) [157] Insulin pump therapy in adults. Didangelos T, Iliadis F. Diabetes Res Clin Pract 2011 Aug; 93 Suppl 1:S109-13.

27) [158] Insulin therapy during hospitalization. Zantidis A, Iliadis F, Didangelos T. Diabetes Res Clin Pract 2011 Aug; 93 Suppl 1:S78-85.

28) [159] Insulin and the heart. Iliadis F, Kadoglou N, Didangelos T. Diabetes Res Clin Pract 2011 Aug; 93 Suppl 1:S86-91.

29) [160] Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study.
Katsiki N, Mikhailidis DP, Gotzamani-Psarrakou A, Didangelos TP, Yovos JG, Karamitsos DT.
Open Cardiovasc Med J. 2011;5:136-47.

30) [161]Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?
Iliadis F, Didangelos T, Ntemka A, Makedou A, Moralidis E, Gotzamani-Psarakou A, Kouloukourgiotou T, Grekas D.
Diabetologia. 2011 Dec;54(12):2987-94

31) [162]Impaired fasting glucose in hypertensive patients: prevalence and cross- sectional analysis of associations with cardiovascular disease.
Tziomalos K, Spanou M, Baltatzi M, Efthymiou E, Psianou K, Papastergiou N, Iliadis F, Didangelos TP, Savopoulos C, Hatzitolios AI.
Diabetes Technol Ther. 2013 Jun;15(6):475-80

32) [163] The prognostic efficacy of myocardial perfusion imaging in optimally treated diabetic patients with no manifestations of coronary artery disease.
Kakaletsis N, Moralidis E, Iliadis F, Hilidis I, Gotzamani-Psarrakou A, Didangelos T. Nucl Med Commun. 2013 Sep;34(9):885-92.

33) [173] Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.
Athyros VG1, Elisaf MS, Alexandrides T, Achimastos A, Ganotakis E, Bilianou E, Karagiannis A, Liberopoulos EN, Tziomalos K, Mikhailidis DP; Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group.
Collaborators (30)
Anagnostis P, Bilianou E, Basdekas S, Didangelos T, Giovas P, Griva T, Filippatos TD, Florentin M, Gazi IF, Gianoglou G, Giouleme O, Gossios TD, Kakafika A, Kapnia E, Kargiotis K, Katsiki N, Kostapanos MS, Liopirakis A, Lioudaki E, Michailidou K, Mitsiou E, Nicolaou V, Pagourelias ED,Paletas K, Petridis D, Pappas S, Saougos V, Theocharidou E, Tolias D, Tsakoudakis N
Angiology. 2012 Jul;63(5):358-66

34) [195] Left Ventricular Systolic and Diastolic Function in Normotensive Type 2 Diabetic Patients With or Without Autonomic Neuropathy: A Radionuclide Ventriculography Study.
Didangelos TP, Arsos G, Karamitsos T, Iliadis F, Papageorgiou A, Moralidis E, Athyros V.
Angiology. 2014 Nov;65(10):877-82

35) [198] TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. Lampropoulou IT, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G. J Diabetes Res. 2014;2014

36) [199] Thyroid Autoimmunity in the Context of Type 2 Diabetes Mellitus: Implications for Vitamin D.
Toulis K, Tsekmekidou X, Potolidis E, Didangelos T, Gotzamani-Psarrakou A, Zebekakis P, Daniilidis M, Yovos J, Kotsa K.
Int J Endocrinol. 2015;2015:71036

37) [223] Peripheral blood monocytes can differentiate into efficient insulin- producing cells in vitro.
Kyventidis A, Tzimagiorgis G, Didangelos T. Hippokratia. 2015 Oct-Dec;19(4):344-51

38) [237] Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges.
Dimas GG, Didangelos TP, Grekas DM.
Curr Vasc Pharmacol. 2017;15(6):557-565

39) [231] Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus.
Didangelos T, Tziomalos K, Margaritidis C, Kontoninas Z, Stergiou I, Tsotoulidis S, Karlafti E, Mourouglakis A, Hatzitolios AI.
J Diabetes Res. 2017;2017:6719239

40) [216] Underestimation of actual insulin needs among people with diabetes type 1 on insulin pump therapy.
Giannoulaki P, Gounitsioti I, Iliadis F, Hatzitolios A, Pappas A, Daskalaki D, Didangelos T.
Clin Nutr ESPEN. 2016 Jun;13:e62.

41) [210] Bolus wizard use has a beneficial effect in glycemic control among people with diabetes type 1 on insulin pump therapy.
Giannoulaki P, Gounitsioti I, Iliadis F, Hatzitolios A, Pappas A, Daskalaki D, Didangelos T.
Clin Nutr ESPEN. 2016 Jun;13:e62-e6

42) [232] Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M, Georgianos PI, Didangelos T, Iliadis F, Makedou A, Hatzitolios A, Liakopoulos V, Grekas DM.
Am J Nephrol. 2017 Dec 22;47(1):21-2

43) [238] Assessment of association between lipoxygenase genes variants in elderly Greek population and type 2 diabetes mellitus.
Tsekmekidou XA, Kotsa KD, Tsetsos FS, Didangelos TP, Georgitsi MA, Roumeliotis AK, Panagoutsos SA, Thodis ED, Theodoridis MT, Papanas NP, Papazoglou DA, Pasadakis PS, Eustratios MS, Paschou PI, Yovos JG.
Diab Vasc Dis Res. 2018 Feb 1:1479164118756241

44) Role of lipids in the pathophysiology of peripheral and autonomic neuropathy and cardiac function in patients with diabetes mellitus type 1. A preliminary report. Didangelos T, Schleicher E, Kantartzis K
Hippokratia. 2018 Apr-Jun;22(2):92

45) Diabetic Cardiovascular Autonomic Neuropathy and Left Ventricular Dysfunction
Didangelos T.
Gen Med (Los Angel) 2013, 1:2

46) Accelerated healing of a diabetic foot ulcer using autologous stromal vascular fraction suspended in platelet-rich plasma.
Didangelos T, Koliakos G, Kouzi K, Arsos G, Kotzampassi K, Tziomalos K, Karamanos D, Hatzitolios AI.
Regen Med. 2018 Apr;13(3):277-281

47) Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema.
Papagianni M, Tziomalos K, Kostaki S, Angelopoulou SM, Christou K, Bouziana SD, Vergou M, Didangelos T, Savopoulos C, Hatzitolios AI.
Am J Cardiovasc Drugs. 2018 Oct;18(5):397-403

48) A Comparative Assessment of Cardiovascular Autonomic Reflex Testing and Cardiac 123I-Metaiodobenzylguanidine Imaging in Patients with Type 1 Diabetes Mellitus without Complications or Cardiovascular Risk Factors.
Didangelos T, Moralidis E, Karlafti E, Tziomalos K, Margaritidis C, Kontoninas Z, Stergiou I, Boulbou M, Papagianni M, Papanastasiou E, Hatzitolios AI.
Int J Endocrinol. 2018 Mar 12;2018:5607208

49) Local Use Of Granulocyte-Macrophages Colony Stimulating Factor In Treatment Of Chronic Diabetic Neuropathic Ulcer (Case Review)
Karlafti E, Savopoulos C, Hatzitolios A, Didangelos T. Georgian Med News. 2018 Apr;(277):21-27

50) Primary Bone Diffuse Large B-cell Lymphoma with Multifocal Osteolytic Lesions: A Rare Entity
Kaiafa G, Didangelos T, Bobos M, Karlafti E, Ztriva E, Kanellos I, Savopoulos C
Gen Med (Los Angeles) 2018, 6:1

51) Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
Milonas D, Didangelos T, Hatzitolios AI, Tziomalos K.
Diabetes Ther. 2019 Apr;10(2):429-435.

52) Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece. Eleftheriadou I, Didangelos T, Pappas AC, Anastasiou E, Vasilopoulos C, Zoupas C, Manes C, Tsatsoulis A, Benroubi M, Pangalos E, Thomakos P, Gerasimidi-Vazeou A, Tentolouris N.
Hormones (Athens). 2019 Dec;18(4):443-450.

53) A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
Liatis S, Iraklianou S, Kazakos K, Mastorakos G, Milios K, Mouslech Z, Noutsou M, Pagkalos E, Sampanis C, and AGREEMENT Investigators (inc. Didangelos T.) BMC Endocrine Disorders (2019) 19:39

54) Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
Didangelos T, Karlafti E, Kotzakioulafi E, Kontoninas Z, Margaritidis C, Giannoulaki P, Kantartzis K.
Nutrients. 2020 Oct 23;12(11):3254. doi: 10.3390/nu12113254

55) TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes Mellitus.
Lampropoulou IT, Stangou Μ, Sarafidis P, Gouliovaki A, Giamalis P, Tsouchnikas I,
Didangelos T, Papagianni Α.
Clin Immunol. 2020 Jun;215:108423

56) Diabetes and Heart Failure: Is it Hyperglycemia or Hyperinsulinemia?
Didangelos T, Kantartzis K.
Curr Vasc Pharmacol. 2020;18(2):148-157.

57) Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors.
Didangelos T, Veves A.
Curr Vasc Pharmacol. 2020;18(2):158-171

58) Impact of Crocus Sativus L. on Metabolic Profile in Patients with Diabetes Mellitus or Metabolic Syndrome: A Systematic Review.
Giannoulaki P, Kotzakioulafi E, Chourdakis M, Hatzitolios A, Didangelos T. Nutrients. 2020 May 14;12(5):1424.

59) Determination of the glomerular filtration rate in patients with type 2 diabetes: An assessment of the agreement between 51Cr-EDTA plasma clearance and 99mTc- DTPA plasma clearance, 99mTc-DTPA renography and plasma creatinine prediction equation.
Moralidis E, Papanastasiou E, Didangelos T, Hilidis I, Siountas A, Arsos G.
Diabetes Res Clin Pract. 2020 Mar;161:108079

60) Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement. Zografou I, Iliadis F, Sambanis C, Didangelos T.
Curr Vasc Pharmacol. 2020;18(5):517-522

61) The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics
Migdalis I, Papanas N, Raptis A, Ioannidis I, Sotiropoulos A, Dimitriadis G, for the Hellenic Diabetic Nephropathy Study (HDNS) Group (incl. Didangelos T.) Diabetes Research and Clinical Practice 166 (2020) 108243

62) Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial.

Didangelos T, Karlafti E, Kotzakioulafi E, Margariti E, Giannoulaki P, Batanis G, Tesfaye S, Kantartzis K.
Nutrients. 2021 Jan 27;13(2):395

63) Is HbA1c an ideal biomarker of well-controlled diabetes?
Kaiafa G, Veneti S, Polychronopoulos G, Pilalas D, Daios S, Kanellos I, Didangelos T, Pagoni S, Savopoulos C.
Postgrad Med J. 2021 Jun;97(1148):380-383

64) Evaluation of Effects of Diabetes Mellitus, Hypercholesterolemia and Hypertension on Bell’s Palsy.
Psillas G, Dimas GG, Sarafidou A, Didangelos T, Perifanis V, Kaiafa G, Mirkopoulou D, Tegos T, Savopoulos C, Constantinidis J.
J Clin Med. 2021 May 27;10(11):2357

65) Detection and Characterization of Phosphorylation, Glycosylation, and Fatty Acid Bound to Fetuin A in Human Blood.
Kovářová M, Kalbacher H, Peter A, Häring HU, Didangelos T, Stefan N, Birkenfeld A, Schleicher E, Kantartzis K.
J Clin Med. 2021 Jan 22;10(3):411.

66) Gestational Diabetes, Colorectal Cancer, Bariatric Surgery, and Weight Loss among Diabetes Mellitus Patients: A Mini Review of the Interplay of Multispecies Probiotics.
Benioudakis E, Karlafti E, Bekiaridou A, Didangelos T, Papavramidis TS.
Nutrients. 2021 Dec 31;14(1):192.

67) Does COVID-19 Clinical Status Associate with Outcome Severity? An Unsupervised Machine Learning Approach for Knowledge Extraction.
Karlafti E, Anagnostis A, Kotzakioulafi E, Vittoraki MC, Eufraimidou A, Kasarjyan K, Eufraimidou K, Dimitriadou G, Kakanis C, Anthopoulos M, Kaiafa G, Savopoulos C, Didangelos T.
J Pers Med. 2021 Dec 17;11(12):1380.

68) Assessment of Hyperglycemia, Hypoglycemia and Inter-Day Glucose Variability Using Continuous Glucose Monitoring among Diabetic Patients on Chronic Hemodialysis.
Divani M, Georgianos PI, Didangelos T, Liakopoulos V, Makedou K, Iliadis F, Savopoulos C, Grekas DM.
J Clin Med. 2021 Sep 12;10(18):4116.

69) Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well- Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring. Margaritidis C, Karlafti E, Kotzakioulafi E, Kantartzis K, Tziomalos K, Kaiafa G, Savopoulos C, Didangelos T.
J Clin Med. 2021 May 5;10(9):1982.

70) Technological Developments and Quality of Life in Type 1 Diabetes Mellitus Patients: A Review of the Modern Insulin Analogues, Continuous Glucose Monitoring and Insulin Pump Therapy.
Benioudakis E, Karlafti E, Kalaitzaki A, Kaiafa G, Savopoulos C, Didangelos T. Curr Diabetes Rev. 2022;18(7):40-48

71) Does the COVID-19 Pandemic Affect Morbidity and Mortality Rates of Emergency General Surgery? A Retrospective Study from a Single-Center Tertiary Greek Hospital.
Karlafti E, Benioudakis ES, Paramythiotis D, Sapalidis K, Kaiafa G, Didangelos T, Michalopoulos A, Kesisoglou I, Savopoulos C.
Medicina (Kaunas). 2021 Nov 1;57(11):1185.

72) The Diabetes Eating Problem Survey-Revised (DEPS-R) in a Greek Adult Population with Type 1 Diabetes Mellitus: Model Comparison Supporting a Single Factor Structure.
Karastogiannidou C, Giannoulaki P, Samaras I, Kotzakioulafi E, Didangelos T,
Bocsan IC, Vassilopoulou E.
Nutrients. 2021 Jul 12;13(7):2375.

73) Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece
Migdalis IN, Papanas N, Ioannidis IM, Sotiropoulos AE, Raptis AE, Dimitriadis GD, on behalf of the Hellenic Diabetic Nephropathy Study (incl. Didangelos T.)
J. Clin. Med. 2021, 10, 2104

74) Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers. Kollari E, Zografou I, Sampanis C, Athyros VG, Didangelos T, Mantzoros CS, Karagiannis A.
Hormones (Athens). 2022 Mar;21(1):91-101

75) Exhaustion and burnout in the healthcare system in Greece: A cross-sectional study among internists during the COVID-19 lockdown.
Karlafti E, Benioudakis ES, Barouxi E, Kaiafa G, Didangelos T, Fountoulakis KN, Pagoni S, Savopoulos C.
Psychiatriki. 2022 Feb 21

76) Depressive symptoms and insulin pump therapy in people with type 1 diabetes mellitus: A systematic review
Benioudakis ES, Karlafti E, Kalaitzaki A, Didangelos T. Psychiatriki. 2022 Feb 21.

77) Insulin Receptors and Insulin Action in the Heart: The Effects of Left Ventricular Assist Devices.
Pantazi, K.; Karlafti, E.; Bekiaridou, A.; Didagelos, M.; Ziakas, A.; Didangelos, T. Biomolecules 2022, 12, 578.

78) Diabetes Mellitus Type 1 during the COVID 19: Psychological symptoms and eating attitudes.
Benioudakis E, Karlafti E, Didangelos T.
Curr Diabetes Rev. 2022 May 16. doi: 10.2174/1573399818666220516105920.
Online ahead of print.